Brands: Baraclude · Entecavir
Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Zydus Pharmaceuticals USA Inc. | unknown | 8 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 8 | SUPPLYING |
| Solco Healthcare US, LLC | unknown | 6 | SUPPLYING |
| Cipla USA Inc. | unknown | 3 | SUPPLYING |
| Yaopharma Co., Ltd. | unknown | 3 | SUPPLYING |
| E.R. Squibb & Sons, L.L.C. | unknown | 2 | SUPPLYING |
| NorthStar RxLLC | unknown | 2 | SUPPLYING |
| Amneal Pharmaceuticals LLC | unknown | 2 | SUPPLYING |
| Epic Pharma, LLC | unknown | 2 | SUPPLYING |
| AvKARE | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Distributed Nationwide in the USA
Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Distributed Nationwide in the USA
Failed Impurity/Degradation Specifications — Recalling firm: Zydus Pharmaceuticals (USA) Inc — U.S. Nationwide
Failed Impurity/Degradation Specifications — Recalling firm: Zydus Pharmaceuticals (USA) Inc — U.S. Nationwide
Pill